Caorsi, R., Lepore, L., Zulian, F., Alessio, M., Stabile, A., Insalaco, A., . . . Gattorno, M. (2013). The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. BioMed Central.
Chicago-tyylinen lähdeviittausCaorsi, Roberta, et al. The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven By the Phenotype Severity Rather Than the Age. BioMed Central, 2013.
MLA-viiteCaorsi, Roberta, et al. The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven By the Phenotype Severity Rather Than the Age. BioMed Central, 2013.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.